These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 7523657)
1. Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity. Foreman MM; Fuller RW; Rasmussen K; Nelson DL; Calligaro DO; Zhang L; Barrett JE; Booher RN; Paget CJ; Flaugh ME J Pharmacol Exp Ther; 1994 Sep; 270(3):1270-81. PubMed ID: 7523657 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist. De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870 [TBL] [Abstract][Full Text] [Related]
3. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210 [TBL] [Abstract][Full Text] [Related]
4. Preclinical studies on LY228729: a potent and selective serotonin1A agonist. Foreman MM; Fuller RW; Leander JD; Benvenga MJ; Wong DT; Nelson DL; Calligaro DO; Swanson SP; Lucot JB; Flaugh ME J Pharmacol Exp Ther; 1993 Oct; 267(1):58-71. PubMed ID: 8229788 [TBL] [Abstract][Full Text] [Related]
5. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin. Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172 [TBL] [Abstract][Full Text] [Related]
6. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors. Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650 [TBL] [Abstract][Full Text] [Related]
7. Functional topography of brain serotonergic pathways in the rat. Hillegaart V Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809 [TBL] [Abstract][Full Text] [Related]
8. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists. Scott PA; Chou JM; Tang H; Frazer A J Pharmacol Exp Ther; 1994 Jul; 270(1):198-208. PubMed ID: 8035316 [TBL] [Abstract][Full Text] [Related]
9. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors. Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774 [TBL] [Abstract][Full Text] [Related]
10. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing. Martin LP; Jackson DM; Wallsten C; Waszczak BL J Pharmacol Exp Ther; 1999 Feb; 288(2):820-6. PubMed ID: 9918594 [TBL] [Abstract][Full Text] [Related]
11. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats. Fornal CA; Litto WJ; Metzler CW; Marrosu F; Tada K; Jacobs BL J Pharmacol Exp Ther; 1994 Sep; 270(3):1345-58. PubMed ID: 7932189 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon. Kleven MS; Koek W J Pharmacol Exp Ther; 1996 Feb; 276(2):388-97. PubMed ID: 8632301 [TBL] [Abstract][Full Text] [Related]
13. Some pharmacological properties of new analogs of MP 3022, the 5-HT1A receptor antagonist. Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E; Paluchowska MH Pol J Pharmacol; 1999; 51(5):405-13. PubMed ID: 10817541 [TBL] [Abstract][Full Text] [Related]
14. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors. Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756 [TBL] [Abstract][Full Text] [Related]
15. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. Casanovas JM; Lésourd M; Artigas F Br J Pharmacol; 1997 Oct; 122(4):733-41. PubMed ID: 9375971 [TBL] [Abstract][Full Text] [Related]
16. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575 [TBL] [Abstract][Full Text] [Related]
17. Studies on the neuronal circuits involved in the discriminative stimulus effects of 5-hydroxytryptamine1A receptor agonists in the rat. Schreiber R; de Vry J J Pharmacol Exp Ther; 1993 May; 265(2):572-9. PubMed ID: 8496807 [TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus effects of 8-hydroxy-2-(di-n-propylamino)tetralin in pigeons and rats: species similarities and differences. Kleven MS; Koek W J Pharmacol Exp Ther; 1998 Jan; 284(1):238-49. PubMed ID: 9435184 [TBL] [Abstract][Full Text] [Related]
19. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons. Van de Kar LD; Li Q; Cabrera TM; Brownfield MS; Battaglia G J Pharmacol Exp Ther; 1998 Jul; 286(1):256-62. PubMed ID: 9655867 [TBL] [Abstract][Full Text] [Related]
20. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice. Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]